The new ultrasound technology may have application as a cancer treatment, used alone or in combination with other cancer treatments.
PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--SonavationTM, Inc., the developer of the biometrics industry’s thinnest and most durable fingerprint sensor, today announced a collaborative research agreement with The University of Texas M. D. Anderson Cancer Center towards the development of novel ultrahigh frequency ultrasound technology.
“This collaborative research agreement with M. D. Anderson will open opportunities leading to possible joint venture companies developing products for cancer treatments.”
The new ultrasound technology may have application as a cancer treatment, used alone or in combination with other cancer treatments. Moreover, this new technology may prove useful to treat skin cancer, certain dermatological conditions, and cosmetics. The collaboration will use Sonavation’s advanced transducer technology implemented in its patented SonicTouchTM biometric fingerprint sensor solutions.
“We are very excited about the promise of this new ultrasound technology and the potential application as a cancer treatment and also for dermatological applications. We hope the collaborative research effort between M. D. Anderson and Sonavation will result in validation of this novel ultrasound technology,” said Tom L. Lee, Director of Active Venture Development at M. D. Anderson. As part of the Office of Technology Commercialization, M. D. Anderson’s Active Venture Development Program focuses on identifying unmet clinical needs for large market opportunities, and then finds novel technology that satisfy that clinical need.
“M. D. Anderson’s reputation for excellence in cancer research, treatment, education and prevention is longstanding,” said Reinhard Warnking, President of Sonavation’s medical division. “This collaborative research agreement with M. D. Anderson will open opportunities leading to possible joint venture companies developing products for cancer treatments.”
About Sonavation
Headquartered in Palm Beach Gardens, Fla., Sonavation designs and manufactures biometric fingerprint sensors providing identification and medical solutions for consumer, government and bio-medical markets. Currently selling to OEMs and ODMs for integration into mobile phones, smart cards, and other electronic devices, the Sonavation product line is designed to enable identification management, protection against identity theft, secure application data and enable a variety of applications including financial processing, transactions and authentication. Sonavation is committed to perfecting biometric sensor technology for Innovating IDTM. For more information, please visit http://www.sonavation.com/.
About M. D. Anderson
The University of Texas M. D. Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. M. D. Anderson is one of only 39 Comprehensive Cancer Centers designated by the National Cancer Institute. For six of the past eight years, M. D. Anderson has ranked No. 1 in cancer care in “America's Best Hospitals,” a survey published annually in U.S. News and World Report.
Get M. D. Anderson News via RSS
SonicTouch, SonicSlide and Innovating ID are trademarks of Sonavation, Inc.
